2016 Immunomic Therapeutics, Inc. Drug Company Research and Development Pipeline Review

Immunomic Therapeutics, Inc.-Product Pipeline Review-2016

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

Description The report provides comprehensive information on the therapeutics under development by Immunomic Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/143821 .

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/143821 .

For more information contact sales@orbisresearch.com Scope - The report provides a snapshot of the pipeline therapeutic landscape of Immunomic Therapeutics, Inc. - The report provides overview of Immunomic Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages - The report assesses Immunomic Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Immunomic Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Browse Complete Report @ http://www.orbisresearch.com/reports/index/immunomic-therapeuticsinc-product-pipeline-review-2016 .

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019

List of Figures Immunomic Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016 7 Immunomic Therapeutics, Inc. - Pipeline by Stage of Development, 2016 9 Immunomic Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016 10 Immunomic Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016 11 Immunomic Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2016 12 Immunomic Therapeutics, Inc. - Pipeline by Top 10 Target, 2016 34 Immunomic Therapeutics, Inc. - Pipeline by Route of Administration, 2016 35 Immunomic Therapeutics, Inc. - Pipeline by Molecule Type, 2016 36 For any enquires before buying, connect with us @ enquiry@orbisresearch.com About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A. Phone No.: +1 (214) 884-6817; +9164101019 Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research Follow us on Twitter: https://twitter.com/orbisresearch Like us on Facebook: https://www.facebook.com/OrbisResearch

www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019